Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Idracare
- Development stage
- Unknown
- Lead developer
- Procare Health
- Administration
- Vaginal
01
Overview
Idracare is a non-hormonal vaginal moisturizing gel developed by Procare Health, specifically formulated to address vaginal dryness and atrophy. The product utilizes niosomal technology to deliver a high concentration of hyaluronic acid into the deeper layers of the vaginal epithelium, promoting tissue hydration and elasticity. In addition to hyaluronic acid, the gel contains Aloe Vera for its soothing and restorative properties and Bioecolia, a prebiotic that supports the health of the vaginal microbiota. It is indicated for women experiencing decreased vaginal secretion due to various factors, including menopause, postpartum recovery, breastfeeding, radiotherapy, or the use of hormonal contraceptives. It is marketed as a medical device and is typically applied twice a week.
- Brand names
- IdracareIdracare®
Beyond the preview
Go deeper on Idracare.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Idracare.